Oral anticoagulation is the optimal choice of antithrombotic therapy for patients with AF at high risk of stroke (CHADS(2) score of ≥ 2). At lower levels of stroke risk, antithrombotic treatment decisions will require a more individualized approach.
Department of Medicine, McMaster University, Hamilton, ON, Canada.
Chest. 2012 Feb;141(2 Suppl):e531S-75S
© Galenicom 1999-2013